Health: licensing; references to licenses for certain substance use disorder services programs in the overdose fatality review act; modify to include those exempt from licensure. Amends sec. 3 of 2023 PA 313 (MCL 330.3023). TIE BAR WITH: HB 5729'26
House Bill 5735 amends the Michigan Overdose Fatality Review Act by revising and expanding several definitions used in the law. The bill updates terms related to overdose review work, including “community overdose review,” “individual overdose review,” “overdose fatality review team,” “multidisciplinary team,” “recovery coach,” and “substance use disorder treatment provider.” It also broadens the definition of hospital to include hospitals licensed under the mental health code, and it clarifies that a substance use disorder treatment provider includes individuals or entities that are either licensed or exempt from licensure in Michigan if they provide FDA-approved medication treatment for substance use disorder.
The bill’s practical effect is to make the overdose fatality review framework more inclusive and better aligned with current treatment and public health practice. By recognizing providers exempt from licensure and expanding the types of institutions and professionals that may be involved, the bill is intended to support more complete overdose case reviews and improve coordination among health care, social service, education, child welfare, and criminal justice systems. The bill is tie-barred to House Bill 5729, meaning it would not take effect unless that related bill is also enacted.
Overall sentiment around the bill appears neutral to supportive, with the text reflecting a technical, administrative update rather than a controversial policy shift. The bill is framed as a refinement to existing overdose review law, suggesting an emphasis on improving implementation and data-sharing rather than changing the core purpose of the act. No committee testimony or recorded votes were provided, so there is no evidence in the supplied materials of organized opposition or strong debate.
The main point of potential contention is the scope of the definition changes, especially the inclusion of providers exempt from licensure and the broader set of institutions and professionals that may participate in overdose reviews. Supporters would likely view these changes as necessary to capture the full range of overdose-related services and improve public health responses, while any concern would likely focus on whether the expanded definitions could complicate administration, privacy, or coordination. Because no discussion transcript or vote history was provided, no specific opposing arguments or named stakeholders can be identified from the record supplied.
HB 5735 amends section 3 of the Overdose Fatality Review Act, 2023 PA 313 (MCL 330.3023), by revising statutory definitions that govern overdose fatality review teams and related processes. It expands the law’s coverage to include hospitals licensed under the mental health code and clarifies that substance use disorder treatment providers include both licensed and exempt providers that use FDA-approved medications for treatment. These changes affect counties, tribes, multidisciplinary review teams, health officers, hospitals, mental health providers, recovery coaches, and substance use disorder treatment providers involved in overdose review and prevention efforts.
The bill appears to have a generally supportive or at least noncontroversial reception based on the materials provided. Its language is technical and definitional, aimed at improving the operation of overdose fatality review teams and aligning the statute with current treatment and public health structures. No votes, committee objections, or recorded debate were supplied, so there is no indication of significant opposition in the available record.
The likely area of contention is the bill’s expansion of who and what can be included in overdose fatality review activities, particularly the reference to substance use disorder treatment providers who are exempt from licensure and the broader inclusion of mental health-code hospitals. Supporters would likely argue these changes improve coordination, data collection, and review accuracy, while critics might question whether the broader definitions could create administrative complexity or raise privacy and implementation concerns. However, the provided materials do not show any specific disputed points, witnesses, or voting splits.